Zymetech

About:

A globally leading company in research, development, production and sales of marine-derived enzymes for therapeutic application

Website: http://www.zymetech.com/

Top Investors: Technology Development Fund

Description:

Zymetech is a globally leading company in research, development, production and sales of marine-derived enzymes for therapeutic application. The company's technology of developing and manufacturing formulations containing marine-derived enzymes is called the Penzyme® technology and is at the core of its intellectual property. Zymetech's use of cod enzymes (called Penzyme®) for therapeutic application is patented-protected in 27 countries. Core and clinical research has demonstrated effectiveness of Penzyme® against a variety of skin conditions, wound healing and viral and bacterial infections.

Total Funding Amount:

$874000

Headquarters Location:

Reykjavík, Gullbringusysla, Iceland

Founded Date:

1999-01-01

Contact Email:

info(AT)zymetech.com

Founders:

Jón Bargai Bjarnason

Number of Employees:

11-50

Last Funding Date:

2015-05-13

IPO Status:

Private

Industries:

© 2025 bioDAO.ai